NCT05251584

Effects of Topical Gentamicin on the Prevention of Peritoneal Dialysis Related Infection

Effects of Topical Gentamicin on the Prevention of Peritoneal Dialysis Related Infection Caused by Pseudomonas Aeruginosa

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Phramongkutklao College of Medicine and Hospital · Academic / Other
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

Peritoneal dialysis-related infection is a complication that leads to peritoneal dialysis catheter removal or patient death. The present study aimed to investigate peritoneal dialysis-related infection, causative pathogens resulting in topical 2% mupirocin ointments period compare with 0.1% gentamicin cream period. Rate of catheter removal, time to first peritoneal dialysis-related infection after apply gentamicin cream.

Conditions

• Peritoneal Dialysis-related Infection

Interventions

Type	Name	Description
DRUG	Mupirocin	Apply mupirocin ointments for prevention of peritoneal dialysis-related infection between 1 January 2021 to 31 December 2021
DRUG	Gentamicin	Apply gentamicin creams for prevention of peritoneal dialysis-related infection for 1 year start after 1 January 2022

Timeline

• Start date: 2021-12-01
• Primary completion: 2023-03-31
• Completion: 2023-05-31
• First posted: 2022-02-22
• Last updated: 2022-02-22

Locations

1 site across 1 country: Thailand